期刊文献+

药物性肝损伤的临床与病理特点分析

An analysis of clinical and pathological features of 148 cases of drug-induced liver injury
下载PDF
导出
摘要 目的探究药物性肝损伤患者的临床特点临床分型与病理损伤分型二者之间的联系。方法收集2018年1月至2022年12月南京市第二医院RUCAM>6分且行肝脏穿刺术患者的年龄、性别、用药史、出入院时间、肝功能指标及病理等资料。结果纳入148例患者,年龄为49.5岁,男女比例为1∶1.96。可疑肝伤损药物分别为中药、西药、中西药混合,所占比例分别为45.3%(67/148)、43.9%(65/148)、10.8%(16/148)。临床分型中,肝细胞损伤型60例(40.5%)。轻、中度肝损伤患者以炎症坏死型为主,重度及急性肝衰竭患者以胆汁淤积型为主。DILI的临床分型与病理分型相关性分析,Cramer’s V值为0.264(P<0.05)。结论病理分型与临床分型间具有一定的相关性,为中等相关。 Objective To analyze the clinical characteristics of drug-induced liver injury(DILI)patients with different clinical classifications and to compare the relationship between clinical and pathological classifications.Methods This study retrospectively screened DILI patients who underwent liver punctures with RUCAM>6 points in Nanjing Second Hospital from January 2018 to December 2022.Data of age,gender,medication history,disease course,liver function indexes and pathological results were collected.Results A total of 200 patients met the inclusion criteria,and 148 patients were included in the analysis after exclusion criteria.The median age of the 148 patients was 49.5 years.The male to female ratio was 1∶1.96.The drugs suspected of liver damage were divided into three categories,i.e.,traditional Chinese medicine,western medicine,and mixed Chinese and western medicine,accounting for 45.3%,43.9%and 10.8%of the cases,respectively.The main clinical classifications were hepatocellular injury(40.5%);The analysis of pathological classifications in DILI patients with different severities showed that inflammatory necrosis type was the main type among mild and moderate cases,and cholestatic type was mainly distributed in severe and acute liver failure cases.The correlation analysis between the clinical and pathological classifications of the DILI patients showed that the Cramer’s V coefficient value was 0.264(P<0.05).Conclusion There is a certain correlation between pathological and clinical classifications of DILI patients but the relationship is moderate.
作者 王双双 熊清芳 胡一帆 陈妙洋 杨永峰 WANG Shuang-shuang;XIONG Qing-fang;HU Yi-fan;CHEN Miao-yang;YANG Yong-feng(School of Public Health,Nanjing Medical University,Jiangsu 211166,China;Department of Hepatology,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine(Nanjing Second Hospital),Jiangsu 210003,China;Department of Hepatology,Teaching Hospital of School of Public Health,Nanjing Medical University(Nanjing Second Hospital),Jiangsu 210003,China)
出处 《肝脏》 2023年第11期1280-1284,共5页 Chinese Hepatology
基金 江苏省卫健委重点科研项目(ZD2021061) 江苏省省中医药科技发展计划项目(YB2020037) 南京中医药大学自然科学基金项目(XZR2020071)。
关键词 药物性肝损伤 临床分型 病理分型 相关性 Drug induced liver injury Clinical classification Pathological classification Correlation
  • 相关文献

参考文献9

二级参考文献48

  • 1张瑞祥.心脑血管病发病率上升的警示[J].中国中医药图书情报杂志,2014,38(1):30-31. 被引量:9
  • 2张琼华,施光峰,李谦,陈明泉.甘草酸二铵肠溶胶囊治疗慢性肝炎2396例[J].中华传染病杂志,2007,25(3):175-176. 被引量:16
  • 3E.Pukenyte,F.X.Lescure,D.Rey,C.Rabaud,B.Hoen,P.Chavanet,A.P.Laiskonis,J.L.Schmit,T.May,Y.Mouton,Y.Yazdanpanah,马玙,张立兴.HIV感染者抗结核治疗过程中严重肝毒性反应的发生率及其危险因素[J].国际结核病与肺部疾病杂志,2007,2(1):30-35. 被引量:13
  • 4许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:349
  • 5Fontana R J, Watkins PB, Bonkovsky HL, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct[J]. Drug Saf, 2009, 32(1) : 55-68. DOI: 10. 2165/00002018-200932010-00005.
  • 6Hoofnagle JH, Serrano J, Knoben JE, et al. LiverTox: a website on drug-induced liver injury [ J]. Hepatology, 2013,57 (3) :873- 874. DOI: 10. 1002/hep. 26175.
  • 7Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug- induced liver injury [ J]. Am J Gastroenterol, 2014, 109 (7) : 950-966. DOI: 10. 1038/ajg. 2014. 131.
  • 8Bjornsson ES, Bergmann OM, Bjornsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland [ J]. Gastroenterology, 2013, 144(7) : 1419-1425. 1425. e1-3; quiz e19-20 . DOI: 10. 1053/j. gastro. 2013.02. 006.
  • 9Bjomsson ES. Epidemiology and risk factors for idiosyncratic drug-induced liver injury [ J ]. Semin Liver Dis, 2014, 34 (2) : 115-122. DOI: 10. 1055/s-0034-1375953.
  • 10Martinez MA, Vuppalanchi R, Fontana RJ, et al. Clinical and histologic features of azithromycin-induced liver injury [ J ]. Clin Gastroenterol Hepatol, 2015, 13 (2) : 369-376. DOI: 10. 1016/ j. cgh. 2014.07. 054.

共引文献594

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部